Catalyst Wire Dossier Catalyst Wire Dossier

COXANTO

OXAPROZIN · SOLA Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for COXANTO, covering 2023-10-20 to 2024-11-21. Get the full timeline:

Most recent: FDA Approved: COXANTO — Supplemental Application (SOLA Pharmaceuticals, LLC)

See pricing